MONTEVIDEO, Uruguay, March 19, 2018 /PRNewswire/ — Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q17 and full year of 2017.
HIGHLIGHTS
Gross revenues for 4Q17 grew 14% in…
